Irinotel 40 mg Injection
  1. Home
  2. Pharma Products
  3. Fresenius Kabi India Pvt Ltd
  4. Irinotel 40 mg Injection

Irinotel 40 mg Injection

Irinotel 40 mg Injection contains irinotecan 40 mg and is an anticancer medicine used mainly in the treatment of colorectal cancer. It is supplied as a 40 mg/2 mL solution for intravenous infusion and is administered by a qualified healthcare professional. The medicine works by inhibiting topoisomerase I, an enzyme involved in DNA replication, thereby helping slow the growth of cancer cells.

BUY NOW

Category

Irinotecan is a topoisomerase I inhibitor used in chemotherapy regimens for metastatic cancer of the colon or rectum. It may be used with fluorouracil and leucovorin or under other clinically appropriate treatment protocols depending on the patient’s condition and treatment history. Irinotecan is generally administered as an intravenous infusion, with dosing and treatment intervals determined by the oncology team according to the selected regimen. Important treatment considerations include monitoring for diarrhea, neutropenia, and other chemotherapy-related toxicities.

Technical Specification

Specification Details
Active Ingredient Irinotecan
Strength 40 mg/2 mL
Concentration 20 mg/mL
Dosage Form Injection, solution
Route of Administration Intravenous infusion
Manufacturer/Marketer Fresenius Kabi India Pvt Ltd

Product Also Known As

Irinotel 40mg Injection, Irinotel 40mg/2ml Injection, Irinotecan 40mg Injection, Irinotecan Hydrochloride Injection 40mg, Irinotecan 40mg/2ml Injection, Irinotecan Kabi 40mg/2ml